File Download

There are no files associated with this item.

Supplementary

Conference Paper: Rational design and fabrication of paclitaxel-curcumin nanosuspensions as a potential inhaled therapy for non-small cell lung cancer

TitleRational design and fabrication of paclitaxel-curcumin nanosuspensions as a potential inhaled therapy for non-small cell lung cancer
Authors
Issue Date2022
PublisherControlled Release Society.
Citation
CRS 2022 Annual Meeting (CRS 2022), Montreal, Canada, July 11-15, 2022. In Final Program: CRS 2022 Annual Meeting & Expo, Montreal, Canada, July 11-15, 2022, p. 29-29 How to Cite?
DescriptionTheme: Advanced Delivery Science
no. 116
Persistent Identifierhttp://hdl.handle.net/10722/314615

 

DC FieldValueLanguage
dc.contributor.authorCHAN, HW-
dc.contributor.authorZhang, X-
dc.contributor.authorChow, SF-
dc.date.accessioned2022-07-22T05:27:57Z-
dc.date.available2022-07-22T05:27:57Z-
dc.date.issued2022-
dc.identifier.citationCRS 2022 Annual Meeting (CRS 2022), Montreal, Canada, July 11-15, 2022. In Final Program: CRS 2022 Annual Meeting & Expo, Montreal, Canada, July 11-15, 2022, p. 29-29-
dc.identifier.urihttp://hdl.handle.net/10722/314615-
dc.descriptionTheme: Advanced Delivery Science-
dc.descriptionno. 116-
dc.languageeng-
dc.publisherControlled Release Society.-
dc.relation.ispartofFinal Program: CRS 2022 Annual Meeting & Expo, Montreal, Canada, July 11-15, 2022-
dc.titleRational design and fabrication of paclitaxel-curcumin nanosuspensions as a potential inhaled therapy for non-small cell lung cancer-
dc.typeConference_Paper-
dc.identifier.emailChow, SF: asfchow@hku.hk-
dc.identifier.authorityChow, SF=rp02296-
dc.identifier.hkuros334391-
dc.identifier.spage29-
dc.identifier.epage29-
dc.publisher.placeCanada-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats